Aurora-A is a determinant of tamoxifen sensitivity through phosphorylation of ERα in breast cancer
出版年份 2013 全文链接
标题
Aurora-A is a determinant of tamoxifen sensitivity through phosphorylation of ERα in breast cancer
作者
关键词
-
出版物
ONCOGENE
Volume 33, Issue 42, Pages 4985-4996
出版商
Springer Nature
发表日期
2013-10-28
DOI
10.1038/onc.2013.444
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The mitotic kinase Aurora-A promotes distant metastases by inducing epithelial-to-mesenchymal transition in ERα+ breast cancer cells
- (2013) A B D'Assoro et al. ONCOGENE
- The role of S6K1 in ER-positive breast cancer
- (2012) Marina K. Holz CELL CYCLE
- The Aurora Kinase A Inhibitor MLN8237 Enhances Cisplatin-Induced Cell Death in Esophageal Adenocarcinoma Cells
- (2012) V. Sehdev et al. MOLECULAR CANCER THERAPEUTICS
- Targeting of the adaptor protein Tab2 as a novel approach to revert tamoxifen resistance in breast cancer cells
- (2012) S Cutrupi et al. ONCOGENE
- Aurora inhibitor MLN8237 in combination with docetaxel enhances apoptosis and anti-tumor activity in mantle cell lymphoma
- (2011) Wenqing Qi et al. BIOCHEMICAL PHARMACOLOGY
- Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel In Vivo Pharmacodynamic Assays
- (2011) M. G. Manfredi et al. CLINICAL CANCER RESEARCH
- Cracking the Estrogen Receptor's Posttranslational Code in Breast Tumors
- (2011) Muriel Le Romancer et al. ENDOCRINE REVIEWS
- PKA-induced phosphorylation of ERα at serine 305 and high PAK1 levels is associated with sensitivity to tamoxifen in ER-positive breast cancer
- (2010) Marleen Kok et al. BREAST CANCER RESEARCH AND TREATMENT
- The Mitotic Kinase Aurora-A Induces Mammary Cell Migration and Breast Cancer Metastasis by Activating the Cofilin-F-actin Pathway
- (2010) L.-h. Wang et al. CANCER RESEARCH
- TRF1 Mediates Mitotic Abnormalities Induced by Aurora-A Overexpression
- (2010) T. Ohishi et al. CANCER RESEARCH
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Estrogen Receptor- Phosphorylation at Serine 305, Nuclear p21-Activated Kinase 1 Expression, and Response to Tamoxifen in Postmenopausal Breast Cancer
- (2010) J. Bostner et al. CLINICAL CANCER RESEARCH
- Clinical significance of estrogen receptor phosphorylation
- (2010) L. C. Murphy et al. ENDOCRINE-RELATED CANCER
- Growth factor stimulation induces a distinct ER cistrome underlying breast cancer endocrine resistance
- (2010) M. Lupien et al. GENES & DEVELOPMENT
- An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
- (2009) Balazs Györffy et al. BREAST CANCER RESEARCH AND TREATMENT
- IKKϵ Phosphorylation of Estrogen Receptor α Ser-167 and Contribution to Tamoxifen Resistance in Breast Cancer
- (2009) Jian-Ping Guo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Aurora-A Phosphorylates, Activates, and Relocalizes the Small GTPase RalA
- (2009) K.-H. Lim et al. MOLECULAR AND CELLULAR BIOLOGY
- Phosphorylation of the oestrogen receptor α at serine 305 and prediction of tamoxifen resistance in breast cancer
- (2008) C Holm et al. JOURNAL OF PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More